Europe Platelet rich Plasma Market to Touch US$ 75.8 Million by 2027 at a 7.1% CAGR | Generated Opportunities for Growth in The Global Europe Platelet-rich Plasma Industry
In sports medicine and orthopedic surgery, platelet-rich plasma (PRP) or platelet-rich fibrin (PRF) are used or examined as surgical adjuvants or regenerative medicine preparations.
The Kits segment of the Europe platelet-rich plasma market was worth US$ 34.9 million in 2019 and is projected to grow at a CAGR of 7.1 percent to US$ 60.4 million by 2027. Rising product approvals are responsible for the segment’s growth over the forecast period.
The prominent players in the Europe Platelet rich Plasma Market are Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., and Estar Technologies Ltd.
Increasing technological advances in PRP therapy are expected to help in the growth of the Europe platelet-rich plasma market. For example, DePuy Synthes’ PEAK PRP System produces highly concentrated 3 ml of PRP from 27 ml of whole blood in just two and a half minutes.
Regulatory changes pertaining to the role of platelet rich plasma treatments are expected to provide lucrative growth opportunities for market players. In July 2019, for example, Health Canada explained that PRP procedures, like Platelet Rich Fibrin treatments, are not the same as cell therapies and, as a result, are not covered by the Policy Position Paper on Autologous Cell Therapy Products.
The market’s growth is expected to be hampered by increasing warnings against the use of PRP. The American College of Rheumatology and the Arthritis Foundation, for example, published the 2019 ACR/AF Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee in January 2020, which advised against the use of PRP injections for the treatment of hip and knee osteoarthritis.
Buy This Complete A Business Report With Flat US $2000 Off @
In terms of value, the knee segment dominated the European platelet-rich plasma market in 2019, accounting for 36.7 percent of the market, led by the elbow and foot & ankle segments, respectively. During the forecast period, the segment is expected to rise due to an increase in the incidence and prevalence of osteoarthritis of the knee.
Expansion of exogenous procoagulant and anticoagulant may bring about clinical side effects and raise the cost of PRP, which has prompted R&D in new methodologies for activation and preparation of PRP without added substances. For example, in May 2018, analysts from Nanfang Hospital of Southern Medical University detailed advancement of a novel strategy named temperature controlled PRP, which doesn’t need utilization of exogenous added substances in the activation and preparation measure.
In January 2020, SHVI PRP Therapy has launched a new website dedicated to the use of platelet-rich plasma (PRP) to treat hair loss.
In January 2019, Generex Biotechnology Corporation has signed a letter of intent to purchase Medisource Partners, an FDA-registered distributor of medical and surgical products, including processing kits for bone marrow aspirates and PRP biologics during surgery.
In December 2019, The Rohrer PiXel8-RF kit for radiofrequency (RF) microneedling treatments and PRP therapy is now available at Maryland Center for Facial Plastic Surgery.
Main points in Europe Platelet rich Plasma Market Report Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Europe Platelet rich Plasma Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Europe Platelet rich Plasma Industry Impact
Chapter 2 Global Europe Platelet rich Plasma Competition by Types, Applications, and Top Regions and Countries
2.1 Global Europe Platelet rich Plasma (Volume and Value) by Type
2.3 Global Europe Platelet rich Plasma (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Europe Platelet rich Plasma Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Europe Platelet rich Plasma Market Analysis
Chapter 6 East Asia Europe Platelet rich Plasma Market Analysis
Chapter 7 Europe Europe Platelet rich Plasma Market Analysis
Chapter 8 South Asia Europe Platelet rich Plasma Market Analysis
Chapter 9 Southeast Asia Europe Platelet rich Plasma Market Analysis
Chapter 10 Middle East Europe Platelet rich Plasma Market Analysis
Chapter 11 Africa Europe Platelet rich Plasma Market Analysis
Chapter 12 Oceania Europe Platelet rich Plasma Market Analysis
Chapter 13 South America Europe Platelet rich Plasma Market Analysis
Chapter 14 Company Profiles and Key Figures in Europe Platelet rich Plasma Business
Chapter 15 Global Europe Platelet rich Plasma Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire